Exenatide: pharmacokinetics, clinical use, and future directions
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1282463
Abstract: ABSTRACT Introduction: The first-in-class glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide, which was initially approved in 2005, is available in twice-daily (BID) and once-weekly (QW) formulations. Clinical trial data suggest both formulations are effective and safe… read more here.
Keywords: pharmacokinetics clinical; clinical use; glp 1ras; exenatide pharmacokinetics ... See more keywords